Ben Long

As a Partner, Ben is responsible for sourcing, evaluating and leading majority and minority investment opportunities, with a particular focus on the healthcare sector.

Ben led our investment in Rosemont Pharmaceuticals, Ridgewall, Pharmaspectra, European LifeCare Group and Lintbells.

Before joining Inflexion from Duke Street in 2017, Ben worked on a number of deals across Europe in the healthcare sector, including the acquisitions of Baywater Healthcare in the UK and Medi-Globe in Germany. Ben has been in private equity since 2006, working at private investment vehicle Echelon Capital where he completed private equity deals in the retail, leisure and TMT space, as well as Barclays Capital, where he worked in their Principal Investments Area.

When not at work Ben enjoys travelling to exotic parts of the globe. He has a first-class degree in Modern History from Oxford.